Sterling, Teague
BioMarin Pharmaceutical Inc.,
United States
2025 Rank: 291819
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1395 out of 112089 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 291819 | 334872 |
| Total Cites | 647 | 658 |
| H-index | 6 | 6 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 1 | 1 |
| Total Cites to Single+First Authored Papers | 401 | 403 |
| Number of Single+First+Last Authored Papers | 1 | 1 |
| Total Cites to Single+First+Last Authored Papers | 401 | 403 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 610 | 618 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.06 |
| Self-Citation Percentage |
1.67%
|
|
Sterling, Teague
BioMarin Pharmaceutical Inc.,
United States
2024 Rank: 261243
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1219 out of 105998 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 261243 | 299394 |
| Total Cites | 631 | 643 |
| H-index | 6 | 6 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 1 | 1 |
| Total Cites to Single+First Authored Papers | 416 | 420 |
| Number of Single+First+Last Authored Papers | 1 | 1 |
| Total Cites to Single+First+Last Authored Papers | 416 | 420 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 591 | 598 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
1.87%
|
|
Sterling, Teague
BioMarin Pharmaceutical Inc.,
United States
2023 Rank: 267025
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Genetics & Heredity
Rank in SubField 1: 1300 out of 99369 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 267025 | 300853 |
| Total Cites | 707 | 713 |
| H-index | 5 | 5 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 1 | 1 |
| Total Cites to Single+First Authored Papers | 457 | 459 |
| Number of Single+First+Last Authored Papers | 1 | 1 |
| Total Cites to Single+First+Last Authored Papers | 457 | 459 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 660 | 664 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.07 |
| Self-Citation Percentage |
0.84%
|
|
Sterling, Teague
BioMarin Pharmaceutical Inc.,
United States
2022 Rank: 226044
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Genetics & Heredity
Rank in SubField 1: 998 out of 94672 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 226044 | 264543 |
| Total Cites | 668 | 678 |
| H-index | 5 | 5 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 1 | 1 |
| Total Cites to Single+First Authored Papers | 431 | 434 |
| Number of Single+First+Last Authored Papers | 1 | 1 |
| Total Cites to Single+First+Last Authored Papers | 431 | 434 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 632 | 638 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.06 |
| Self-Citation Percentage |
1.47%
|
|
Sterling, Teague
BioMarin Pharmaceutical Inc.,
United States
2021 Rank: 282014
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1300 out of 88725 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 282014 | 321349 |
| Total Cites | 923 | 939 |
| H-index | 6 | 6 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 1 | 1 |
| Total Cites to Single+First Authored Papers | 527 | 532 |
| Number of Single+First+Last Authored Papers | 1 | 1 |
| Total Cites to Single+First+Last Authored Papers | 527 | 532 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 872 | 882 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.06 |
| Self-Citation Percentage |
1.70%
|
|
Sterling, Teague
University of California, San Francisco,
United States
2020 Rank: 307250
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Chemistry
SubField 1:
Medicinal & Biomolecular Chemistry
SubField 2:
Endocrinology & Metabolism
Rank in SubField 1: 1554 out of 80622 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 307250 | 349119 |
| Total Cites | 618 | 631 |
| H-index | 7 | 7 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 1 | 1 |
| Total Cites to Single+First Authored Papers | 226 | 229 |
| Number of Single+First+Last Authored Papers | 1 | 1 |
| Total Cites to Single+First+Last Authored Papers | 226 | 229 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 584 | 594 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.06 |
| Self-Citation Percentage |
2.06%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.